Trial yields positive results for Lymphoseek

05/10/2009 | ScienceDaily

A Phase III study involving early-stage breast cancer patients showed that the radiopharmaceutical Lymphoseek can detect 100% of cancer-positive lymph nodes quicker and in a more convenient and targeted way than standard methods. "These results will really enable molecular biology to enter the operating room for lymph node detection," a researcher said.

View Full Article in:

ScienceDaily

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA